Skip to main content
. 2016 May 5;1:8. doi: 10.1186/s41181-016-0013-5

Table 3.

Tumor-to-background ratios at different time points after injection of 44Sc/68Ga-labeled DOTA-NOC and NODAGA-NOC

44Sc-DOTA-NOC 68Ga-DOTA-NOC
AR42J 30 min p.i. 2 h p.i. 5 h p.i. 30 min p.i. 2 h p.i.
Tumor-to-blood 3.69 ± 1.52 58.2 ± 6.64 52.0 ± 4.38 5.22 ± 1.07 46.2 ± 2.28
Tumor-to-liver 6.87 ± 2.38 13.1 ± 2.16 15.7 ± 2.82 2.44 ± 0.36 2.22 ± 0.22
Tumor-to-kidney 0.79 ± 0.19 1.01 ± 0.06 0.85 ± 0.04 1.20 ± 0.21 1.41 ± 0.18
44Sc-NODAGA-NOC 68Ga-NODAGA-NOC
AR42J 30 min p.i. 2 h p.i. 5 h p.i. 30 min p.i. 2 h p.i.
Tumor-to-blood 5.23 ± 0.22 50.3 ± 16.8 78.6 ± 6.95 4.32 ± 0.58 76.0 ± 4.31
Tumor-to-liver 8.13 ± 0.72 11.9 ± 3.26 11.6 ± 1.51 4.36 ± 0.91 5.88 ± 0.68
Tumor-to-kidney 0.80 ± 0.10 1.22 ± 0.34 0.87 ± 0.24 0.58 ± 0.10 0.85 ± 0.08